Researchers have shown that activation of the protein YAP, which helps tumours grow, differs between two- and three-dimensional culture models, pointing to more predictive systems for testing cancer ...

Tarlatamab is a bispecific T-cell engager that binds to DLL3 expressed on the surface of tumor cells and CD3 expressed on the surface of T-cells.

Roche has claimed a breakthrough designation from the FDA for a cancer test that combines an antibody assay with ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Boehringer Ingelheim unveiled new data from its top oncology prospect zongertinib, further backing the drug’s prowess in ...

the drug has generate promising results in advanced non-small cell lung cancer (NSCLC). Data from the TROPION-Lung02 reported at the World Congress on Lung Cancer (WCLC) showed an overall response ...